Viatris's second quarter revenue of $3.8B beat estimates as the company raised its full-year 2026 guidance.

Viatris reported second quarter total revenues of $3.8 billion, a 5% increase year-over-year, and an adjusted EPS of $0.69, up 11%. The company posted a U.S. GAAP net loss of $119 million, or $(0.10) per share, primarily due to a non-cash charge related to the planned sale of its Tyrvaya product rights. Citing strong first-half performance, Viatris raised its full-year 2026 guidance for all financial metrics.

Key Highlights

• Total revenues of $3.8 billion grew 5% year-over-year, surpassing analyst estimates of $3.66 billion, driven by new product sales and strong growth in Greater China.
• Adjusted EPS came in at $0.69, up 11% from the prior year and beating the consensus estimate of $0.62.
• Revenue from the Developed Markets segment was $2.19 billion, slightly ahead of the $2.18 billion analyst forecast and up 4% year-over-year.
• The company raised the midpoints of its full-year 2026 financial guidance for revenue, adjusted EBITDA, and adjusted EPS.